SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NORTH AMERICAN VACCINE (NVX)
NVX 1.510-3.8%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Don W Stone who wrote ()2/21/1997 3:37:00 PM
From: Don W Stone   of 21
 
From Strategic Investment, feb 19, 1997
This particular piece was written by a James Davidson of Strategic Advisors Overseas Ltd., a money managemenrt firm.
Here are some excerpts that if you are a bull you will love to here that are part of a small clip on NVX in this issue.

"We anticipate an early FDA approval in the U.S."
"
"What makes it particularly interesting is that the stock has the largest relative short interest on the American Stock Exchange, equivalent to 61 days float. we expect the short sellers to fall into panic buying when the FDA approval is announced."
He goes on to recommend June 30 Calls but not to pay over $3.25 per call.
Now you have heard this before , but it is always good to here it from another source.
I do not know , nor for that matter, ever heard of James Davidson before, but based on these comments I rate him as a very astute, intelligent, and very successful stock picker and investment advisor. :-} :-} :-] I do like the way he thinks.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext